- Waldenström Macroglobulinemia
- Melanoma
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Childhood Cancers
- Gastric Cancer
- Gynecologic Cancer
- Head & Neck Cancer
- Immunotherapy
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma Cancer
- Mesothelioma
- MPN
- MDS
- Myeloma
- Prostate Cancer
- Rare Cancers
- Sarcoma
- Skin Cancer
- Testicular Cancer
- Thyroid Cancer
When to Treat Relapsed Myeloma
Here is what one expert says about the right time to start treating relapsed multiple myeloma.
Sagar Lonial, M.D., professor and chair of the Department of Hematology and Medical Oncology and chief medical officer of the Winship Cancer Institute of Emory University discusses the criteria for treating patients with relapsed myeloma.
First, it is essential to determine if the patient needs to be treated at all. According to the International Myeloma Working Group, anyone who shows a re-emergence of symptomatic myeloma, per the CRAB criteria (calcium levels, renal dysfunction, anemia and bone lesions) should be treated.
However, Lonial mentioned that just because someone has a biochemical relapse, that doesn't always mean that they need treatment. Instead, Lonial may watch these patients, and take into consideration other possible factors, such as their genetic risk.
Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy-Related Cancer
November 29th 2023The FDA announced rare instances of secondary diseases or cancers from CAR-T cell therapy, though this is not the first time that oncology treatments have been associated with secondary diseases.
Read More
